Onkologie 2020: 14(Suppl.B): 37-39 | DOI: 10.36290/xon.2020.034
Case report of the meaning therapeutical response of the NSCLC after pembrolizumab monotherapy
- Plicní oddělení, Vítkovická nemocnice, a. s., Ostrava-Vítkovice
The authors present a case report of a successful treatment by pembrolizumab in an elderly man with with adenocarcioma of lung. The aim is to show the case of the successfull anticancer therapy in elderly patient, the today standard therapy by immunotherapy outside of clinical trials in the Czech republic.
Keywords: NSCLC, immunotherapy, elderly patients, pembrolizumab, KEYNOTE-024.
Published: June 2, 2020 Show citation
References
- Brahmer J, Drake CG, Wollner I, et al. Phase I study of single-agent anti-programmed death-1 (MDX-1106) in refractory solid tumors: safety, clinical activity, pharmacodynamics, and immunologic correlates. J Clin Oncol. 2010; 28: 3167-3175.
Go to original source... 
Go to PubMed... - Reck M, Rodríguez-Abreu D, Robinson AG, et al. Pembrolizumab versus Chemotherapy for PD-L1-Positive Non-Small-Cell Lung Cancer. N Engl J Med. 2016 Nov 10; 375(19). Go to original source... Go to PubMed...
- Reck M, Rodríguez-Abreu D, Robinson AG, et al. Updated Analysis of KEYNOTE-024: Pembrolizumab Versus Platinum-Based Chemotherapy for Advanced Non-Small-Cell Lung Cancer With PD-L1 Tumor Proportion Score of 50 % or Greater. J Clin Oncol. 2019 Mar 1; 37(7): 537-546. doi: 10.1200/JCO.18.00149. Epub 2019 Jan 8. Go to original source... Go to PubMed...
- Gandhi L, Rodríguez-Abreu D, Gadgeel S, et al. Pembrolizumab plus Chemotherapy in Metastatic Non-Small-Cell Lung Cancer. N Engl J Med. 2018 May 31; 378(22): 2078-2092. Go to original source... Go to PubMed...
- Aguilar EJ, Ricciuti B, Gainor JF, et al. Outcomes to first-line pembrolizumab in patients with non-small cell lung cancer and very high PD-L1 expression. Ann Oncol. 2019 Oct; 30(10): 1653-1659. Go to original source... Go to PubMed...
- Havel L. Is age limiting factor for nivolumab treatment? Onkol Revue 2018; 5(5): 57-59.
- www.sukl.cz
- Kanesvaran R, Cordoba R, Maggiore R, et al. Immunotherapy in Older Adults With Advanced Cancers: Implications for Clinical Decision-Making and Future Research. American Society of Clinical Oncology Educational Book 2018; 38: 400-414. Go to original source... Go to PubMed...
- Kim R, Keam B, Hahn S, et al. Firstline Pembrolizumab Versus Pembrolizumab Plus Chemotherapy Versus Chemotherapy Alone in Non-small-cell Lung Cancer: A Systematic Review and Network Meta-analysis.Clin Lung Cancer. 2019 Sep; 20(5): 331-338. Go to original source... Go to PubMed...